Have You experienced a side effect?
and Vote

Yes, Severe
Yes, Moderate
Yes, Minor
No
Discuss Results
1.5 million people annually are harmed from drug errors. Side Effects Reported Today:

Don't Risk Your Health!
Ask a Health Expert Now


CATHETER SITE HAEMORRHAGE side effect

What is CATHETER SITE HAEMORRHAGE ?
Help Community - Describe Your Side Effect   Search FDA Side Effects   Ask Health Expert   CATHETER SITE HAEMORRHAGE and Recently Reported Side Effects   CATHETER SITE HAEMORRHAGE and 15 most Active Side Effect polls   CATHETER SITE HAEMORRHAGE and featured health surveys   Substances toxic to Health   Recent Hospital reviews   Comments about Side Effects   Hospital Quality reviews   Homecare Quality reviews
Health Expert

A Health Expert wants to answer your question.

Please provide details below.



Drugs associated with CATHETER SITE HAEMORRHAGE

ALBUMINAR  ANGIOMAX  ARIXTRA  ASPIRIN  AUGMENTIN  AVONEX  BENEFIX  BEVACIZUMAB  BYETTA  CAMPATH  CEFAZOLIN  CYTARABINE  DROTRECOGIN  DURAGESIC  ENOXAPARIN  EPTIFIBATIDE  ERLOTINIB  FLOLAN  FRAGMIN  HEPARIN  INTEGRILIN  KETOROLAC  LEPIRUDIN  LOVENOX  METHOTREXATE  MILRINONE  REBIF  REOPRO  REVLIMID  SULPERAZONE  TRACLEER  VELCADE  WARFARIN  XIGRIS  ZOCOR  


Sulperazone Side Effects Report #5649650-5
Physician from PHILIPPINES reported SULPERAZONE problem on Feb 21, 2008. Male patient, 68 years of age, was diagnosed with intestinal obstruction and was treated with SULPERAZONE. After drug was administered, patient experienced the following problems/side effects: catheter site haemorrhage, injection site haemorrhage, . SULPERAZONE dosage: unknown. During the same period patient was treated with POLYSTYRENE SULFONATE, NEXIUM. Patient recovered.

Enoxaparin Side Effects Report #5671166-0
ENOXAPARIN problem was reported by a Pharmacist from UNITED STATES on Mar 17, 2008. Male patient, 45 years of age, weighting 256.8 lb, was treated with ENOXAPARIN. After drug was administered, patient experienced the following problems/side effects: catheter site haemorrhage, ecchymosis, injection site bruising, . ENOXAPARIN dosage: 150 MG UD OTHER. During the same period patient was treated with ASPIRIN. Patient was hospitalized. Patient recovered.

Arixtra Side Effects Report #5615118-5
Consumer or non-health professional from UNITED STATES reported ARIXTRA problem on June 01, 2007. Male patient, 55 years of age, was diagnosed with deep vein thrombosis and was treated with ARIXTRA. After drug was administered, patient experienced the following problems/side effects: catheter site haemorrhage, . ARIXTRA dosage: 7.5MG PER DAY. During the same period patient was treated with AMIKACIN, ZOSYN, NEXIUM, GUAIFENESIN, MAGNESIUM OXIDE, POTASSIUM CHLORIDE, THIAMINE. Patient recovered.

Heparin Side Effects Report #5626566-1
HEPARIN problem was reported by a Pharmacist from UNITED STATES on Feb 14, 2008. Male patient, 65 years of age, was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: catheter site haemorrhage, . HEPARIN dosage: unknown. Patient was hospitalized. Patient recovered.


Angiomax Side Effects Report #5655605-7
Health Professional from UNITED STATES reported ANGIOMAX problem on Sept 06, 2007. Female patient, 64 years of age, weighting 200.4 lb, was diagnosed with percutaneous coronary intervention and was treated with ANGIOMAX. After drug was administered, patient experienced the following problems/side effects: catheter site haemorrhage, thrombosis in device, . ANGIOMAX dosage: 13.5 ML, BOLUS, IV BOLUS. During the same period patient was treated with ASPIRIN, PLAVIX. Patient recovered.

Angiomax Side Effects Report #5660231-X
ANGIOMAX problem was reported by a Health Professional from UNITED STATES on May 01, 2007. Female patient, 84 years of age, weighting 200.0 lb, was diagnosed with percutaneous coronary intervention and was treated with ANGIOMAX. After drug was administered, patient experienced the following problems/side effects: catheter site haemorrhage, . ANGIOMAX dosage: 13.5 ML, BOLUS, IV BOLUS. During the same period patient was treated with CLOPIDOGREL. Patient was hospitalized. Patient recovered.

Angiomax Side Effects Report #5660247-3
Health Professional from UNITED STATES reported ANGIOMAX problem on May 01, 2007. Female patient, 84 years of age, weighting 200.0 lb, was diagnosed with percutaneous coronary intervention and was treated with ANGIOMAX. After drug was administered, patient experienced the following problems/side effects: catheter site haemorrhage, . ANGIOMAX dosage: 13.5 ML, BOLUS, IV BOLUS; 31.5 ML, HR, INTRAVENOUS. During the same period patient was treated with CLOPIDOGREL. Patient was hospitalized. Patient recovered.

Fragmin Side Effects Report #5662589-4
FRAGMIN problem was reported by a Pharmacist from UNITED STATES on Aug 14, 2007. Female patient, 86 years of age, was diagnosed with thrombosis prophylaxis and was treated with FRAGMIN. After drug was administered, patient experienced the following problems/side effects: catheter site haemorrhage, . FRAGMIN dosage: unknown. During the same period patient was treated with PLAVIX, BABYPYRIN. Patient recovered.

Avonex Side Effects Report #5568228-5
Consumer or non-health professional from UNITED STATES reported AVONEX problem on Dec 07, 2007. Male patient, 36 years of age, was diagnosed with multiple sclerosis and was treated with AVONEX. After drug was administered, patient experienced the following problems/side effects: catheter site haemorrhage, urinary tract infection, . AVONEX dosage: unknown. Patient was hospitalized. Patient recovered.


Xigris Side Effects Report #5482663-5
XIGRIS problem was reported by a Physician from UNITED STATES on Oct 01, 2007. Male patient, 64 years of age, was diagnosed with sepsis and was treated with XIGRIS. After drug was administered, patient experienced the following problems/side effects: catheter site haemorrhage, haemodialysis, wound haemorrhage, . XIGRIS dosage: unknown. Patient died.

Xigris Side Effects Report #5493470-1
Physician from UNITED STATES reported XIGRIS problem on Oct 10, 2007. Male patient, 64 years of age, was diagnosed with sepsis and was treated with XIGRIS. After drug was administered, patient experienced the following problems/side effects: catheter site haemorrhage, renal failure, wound haemorrhage, . XIGRIS dosage: unknown. Patient died.

Velcade Side Effects Report #5468626-4
VELCADE problem was reported by a Physician from GREECE on Sept 12, 2007. Male patient, 63 years of age, weighting 165.3 lb, was diagnosed with plasmacytoma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: catheter site haemorrhage, postoperative wound complication, wound haemorrhage, . VELCADE dosage: 1.30 MG/M2, INTRAVENOUS. Patient was hospitalized. Patient recovered.

Fragmin Side Effects Report #5425358-6
Pharmacist from UNITED STATES reported FRAGMIN problem on Aug 14, 2007. Female patient, 82 years of age, was diagnosed with prophylaxis and was treated with FRAGMIN. After drug was administered, patient experienced the following problems/side effects: catheter site haemorrhage, deep vein thrombosis, epistaxis, gastrointestinal haemorrhage, . FRAGMIN dosage: unknown. During the same period patient was treated with PLAVIX. Patient died on 07/27/2007.

Warfarin Side Effects Report #5765611-X
WARFARIN problem was reported by a Pharmacist from UNITED STATES on June 06, 2008. Male patient, 83 years of age, weighting 116.8 lb, was diagnosed with atrial fibrillation and was treated with WARFARIN. After drug was administered, patient experienced the following problems/side effects: catheter site haemorrhage, fatigue, gastrointestinal haemorrhage, haematocrit decreased, haemoglobin decreased, . WARFARIN dosage: 1 MG EVERY DAY PO. Patient was hospitalized. Patient recovered.


Ketorolac Side Effects Report #5766774-2
Physician from UNITED STATES reported KETOROLAC TROMETHAMINE problem on June 03, 2008. Female patient, 50 years of age, was diagnosed with pain management and was treated with KETOROLAC TROMETHAMINE. After drug was administered, patient experienced the following problems/side effects: catheter site haemorrhage, hypoprothrombinaemia, renal failure acute, . KETOROLAC TROMETHAMINE dosage: unknown. During the same period patient was treated with NAFCILLIN, RIFAMPIN, VANCOMYCIN, CIPROFLOXACIN, IMIPENEM, CEFAZOLIN. Patient was hospitalized. Patient recovered.

Cefazolin Side Effects Report #5774773-X
CEFAZOLIN problem was reported by a Pharmacist from UNITED STATES on May 30, 2008. Female patient, 50 years of age, was treated with CEFAZOLIN. After drug was administered, patient experienced the following problems/side effects: catheter site haemorrhage, haematocrit decreased, haemoglobin decreased, hypoprothrombinaemia, international normalised ratio increased, . CEFAZOLIN dosage: unknown. During the same period patient was treated with ACETAMINOPHEN, EPOETIN ALFA, HEPARIN, METOPROLOL TARTRATE, SEVELAMER, SENNOSIDES, MONTELUKAST, LORATADINE. Patient recovered.

Benefix Side Effects Report #5776258-3
Health Professional from UNITED STATES reported BENEFIX problem on June 06, 2008. Male patient, weighting 33.16 lb, was diagnosed with factor ix deficiency and was treated with BENEFIX. After drug was administered, patient experienced the following problems/side effects: catheter site haemorrhage, factor ix inhibition, . BENEFIX dosage: unknown. Patient was hospitalized. Patient recovered.

Lovenox Side Effects Report #5780297-6
LOVENOX problem was reported by a Pharmacist from UNITED STATES on June 10, 2008. Female patient, 65 years of age, weighting 127.9 lb, was diagnosed with prophylaxis and was treated with LOVENOX. After drug was administered, patient experienced the following problems/side effects: catheter site haemorrhage, . LOVENOX dosage: DOSE: 40 MG - 3 DOSES. Patient recovered.

Heparin Side Effects Report #5739305-0
Consumer or non-health professional from UNITED STATES reported HEPARIN problem on May 15, 2008. Female patient, weighting 9.04 lb, was diagnosed with postoperative thrombosis and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: catheter site haemorrhage, postoperative thrombosis, respiratory disorder, retroperitoneal haemorrhage, . HEPARIN dosage: unknown. Patient died on 12/18/2007.


Augmentin Side Effects Report #5709651-5
AUGMENTIN problem was reported by a Consumer or non-health professional from SWITZERLAND on Apr 11, 2008. Female patient, 86 years of age, was diagnosed with lung infection, cardiogenic shock and was treated with AUGMENTIN. After drug was administered, patient experienced the following problems/side effects: catheter site haemorrhage, thrombocytopenia, . AUGMENTIN dosage: 1200MG THREE TIMES PER DAY. During the same period patient was treated with REOPRO, LIQUAEMIN, CORDARONE, LIDOCAINE, PRIMPERAN, VISIPAQUE, DOBUTAMINE HYDROCHLORIDE, LASIX. Patient was hospitalized. Patient recovered.

Aspirin Side Effects Report #5721307-1
Physician from CANADA reported ASPIRIN problem on Apr 17, 2008. Female patient, 78 years of age, was diagnosed with acute coronary syndrome, chest pain, dyslipidaemia, hypertension and was treated with ASPIRIN. After drug was administered, patient experienced the following problems/side effects: catheter site haemorrhage, . ASPIRIN dosage: unknown. During the same period patient was treated with ENOXAPARIN, PLAVIX, INTEGRILIN, NITROGLYCERIN, ATORVASTATIN CALCIUM, ALTACE, TIAZAC. Patient was hospitalized. Patient recovered.

Integrilin Side Effects Report #5327205-X
INTEGRILIN problem was reported by a Physician from UNITED STATES on May 02, 2007. Female patient, 84 years of age, was diagnosed with angioplasty and was treated with INTEGRILIN. After drug was administered, patient experienced the following problems/side effects: catheter site haemorrhage, muscle haemorrhage, retroperitoneal haemorrhage, shock, . INTEGRILIN dosage: unknown. Patient recovered.

Bevacizumab Side Effects Report #5333419-5
Health Professional from UNITED STATES reported BEVACIZUMAB problem on May 22, 2007. Female patient, 72 years of age, weighting 204.8 lb, was diagnosed with ovarian cancer recurrent and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: catheter site haemorrhage, thrombocytopenia, . BEVACIZUMAB dosage: 10MG/KG Q 2 WKS/ 4 WK CYCL IV DRIP. During the same period patient was treated with TOPOTECAN. Patient recovered.

Rebif Side Effects Report #5301506-3
REBIF problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 05, 2007. Female patient, 46 years of age, was diagnosed with multiple sclerosis and was treated with REBIF. After drug was administered, patient experienced the following problems/side effects: catheter site haemorrhage, deep vein thrombosis, injection site haematoma, international normalised ratio increased, multiple sclerosis, post procedural haemorrhage, . REBIF dosage: unknown. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5314283-7
Health Professional from UNITED STATES reported ERLOTINIB problem on Apr 10, 2007. Male patient, 56 years of age, weighting 110.0 lb, was diagnosed with non-small cell lung cancer and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: catheter site haemorrhage, dizziness, haematemesis, haemoglobin decreased, rectal haemorrhage, . ERLOTINIB dosage: 50 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB, ISOSORBIDE MONONITRATE, LIPITOR, ZETIA, COREG, GLIPIZIDE, ALTACE, NEXIUM. Patient was hospitalized. Patient recovered.

Heparin Side Effects Report #5256263-6
HEPARIN problem was reported by a Pharmacist from UNITED STATES on Mar 02, 2007. Female patient, weighting 166.2 lb, was diagnosed with dialysis, prophylaxis, pulmonary embolism, thrombosis prophylaxis and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: catheter site haemorrhage, dialysis, heparin-induced thrombocytopenia, . HEPARIN dosage: unknown. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5662194-X
Physician from UNITED STATES reported BEVACIZUMAB problem on Mar 03, 2008. Female patient, weighting 132.1 lb, was diagnosed with non-small cell lung cancer and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, catheter site haemorrhage, international normalised ratio increased, mouth haemorrhage, platelet count decreased, pneumothorax, tumour necrosis, unresponsive to stimuli, ventricular fibrillation, . BEVACIZUMAB dosage: 855 MG, Q3W. During the same period patient was treated with DOCETAXEL, CARBOPLATIN, ADVAIR DISKUS, ALBUTEROL, DEXAMETHASONE, HYDROCHLOROTHIAZIDE, PANTOPRAZOLE, PROCHLORPERAZINE MALEATE. Patient died on 03/01/2008.

Zocor Side Effects Report #5671575-X
ZOCOR problem was reported by a Health Professional from FRANCE on Mar 17, 2008. Male patient, 79 years of age, was diagnosed with hypercholesterolaemia, atrial fibrillation, hypertension and was treated with ZOCOR. After drug was administered, patient experienced the following problems/side effects: anaemia, catheter site haemorrhage, epistaxis, haematuria, . ZOCOR dosage: unknown. During the same period patient was treated with FLUINDIONE, ALLOPURINOL, TERBUTALINE SULPHATE, SPIRONOLACTONE, PERINDOPRIL ERBUMINE, ATENOLOL. Patient was hospitalized. Patient recovered.

Cytarabine Side Effects Report #5557143-9
Consumer or non-health professional from UNITED STATES reported CYTARABINE problem on Dec 11, 2007. Male patient, weighting 144.4 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: cardio-respiratory arrest, catheter site haemorrhage, cholestasis, coagulopathy, diarrhoea, epistaxis, haemodialysis, haemodynamic instability, . CYTARABINE dosage: 1000 MG. During the same period patient was treated with METHOTREXATE, VINCRISTINE SULPHATE. Patient was hospitalized. Patient recovered.

Zocor Side Effects Report #5557819-3
ZOCOR problem was reported by a Health Professional from FRANCE on Dec 10, 2007. Male patient, 79 years of age, was diagnosed with hypercholesterolaemia, atrial fibrillation, hypertension and was treated with ZOCOR. After drug was administered, patient experienced the following problems/side effects: anaemia, catheter site haemorrhage, epistaxis, haematuria, . ZOCOR dosage: unknown. During the same period patient was treated with FLUINDIONE, ALLOPURINOL, TERBUTALINE SULPHATE, SPIRONOLACTONE, PERINDOPRIL ERBUMINE, ATENOLOL. Patient was hospitalized. Patient recovered.

Methotrexate Side Effects Report #5519225-7
Consumer or non-health professional from UNITED STATES reported METHOTREXATE problem on Nov 14, 2007. Male patient, weighting 144.4 lb, was treated with METHOTREXATE. After drug was administered, patient experienced the following problems/side effects: cardio-respiratory arrest, catheter site haemorrhage, cholestasis, diarrhoea, haemodialysis, haemodynamic instability, hepatic cirrhosis, . METHOTREXATE dosage: 910 MG. During the same period patient was treated with VINCRISTINE SULPHATE. Patient was hospitalized. Patient recovered.

Drotrecogin Side Effects Report #5503149-5
DROTRECOGIN ALFA problem was reported by a Physician from HUNGARY on Oct 24, 2007. Male patient, 62 years of age, weighting 286.6 lb, was diagnosed with septic shock and was treated with DROTRECOGIN ALFA. After drug was administered, patient experienced the following problems/side effects: cardio-respiratory distress, catheter site haemorrhage, . DROTRECOGIN ALFA dosage: 20 MG, OTHER. During the same period patient was treated with POTASSIUM CHLORIDE, FUROSEMIDE, SORTIS, ASPIRIN, DIOVAN, NEBILET. Patient died on 09/28/2007.

Lepirudin Side Effects Report #5426099-1
Pharmacist from UNITED STATES reported LEPIRUDIN problem on Aug 23, 2007. Female patient, 26 years of age, was treated with LEPIRUDIN. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, catheter site haemorrhage, condition aggravated, haemoptysis, . LEPIRUDIN dosage: unknown. Patient recovered.

Heparin Side Effects Report #5732390-1
HEPARIN problem was reported by a Health Professional from UNITED STATES on May 01, 2008. Male patient, 63 years of age, weighting 277.8 lb, was diagnosed with prophylaxis and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: catheter site haematoma, catheter site haemorrhage, contusion, platelet count decreased, red blood cell count decreased, skin discolouration, . HEPARIN dosage: unknown. During the same period patient was treated with SIMVASTATIN, METOPROLOL TARTRATE. Patient was hospitalized. Patient recovered.

Lovenox Side Effects Report #5256983-3
Pharmacist from UNITED STATES reported LOVENOX problem on Mar 05, 2007. Male patient, 32 years of age, weighting 154.3 lb, was diagnosed with thrombosis prophylaxis and was treated with LOVENOX. After drug was administered, patient experienced the following problems/side effects: antibody test positive, catheter site haemorrhage, ecchymosis, heparin-induced thrombocytopenia test, post procedural haemorrhage, . LOVENOX dosage: 40MG DAILY SQ. During the same period patient was treated with FENTANYL, NEURONTIN, BACLOFEN, PROTONIX, COLACE, SENNA, FERROUS SULPHATE, FOLIC ACID. Patient was hospitalized. Patient recovered.

Heparin Side Effects Report #5265873-1
HEPARIN problem was reported by a Pharmacist from UNITED STATES on Mar 12, 2007. Male patient, 59 years of age, weighting 249.1 lb, was diagnosed with thrombosis prophylaxis and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, catheter site haemorrhage, incorrect dose administered, pain, post procedural haemorrhage, . HEPARIN dosage: unknown. Patient was hospitalized. Patient recovered.

Campath Side Effects Report #5275215-3
Health Professional from UNITED STATES reported CAMPATH problem on Mar 20, 2007. Male patient, 58 years of age, was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: bacteraemia, catheter site haemorrhage, cerebral atrophy, cholelithiasis, coagulopathy, dialysis, diarrhoea, enterococcal infection, . CAMPATH dosage: 30 MG/DAY, D1-5 EVERY 28 DAYS. During the same period patient was treated with FLUDARA, NEULASTA, LEVAQUIN, TYLENOL, BACTRIM DS, FAMVIR, FLAGYL. Patient was hospitalized. Patient died on 11/28/2006.

Albuminar Side Effects Report #5695380-3
ALBUMINAR problem was reported by a Pharmacist from UNITED STATES on Mar 13, 2008. Female patient, 65 years of age, weighting 238.3 lb, was diagnosed with myasthenia gravis, plasmapheresis and was treated with ALBUMINAR. After drug was administered, patient experienced the following problems/side effects: blood fibrinogen decreased, blood glucose increased, catheter site haemorrhage, haemolysis, international normalised ratio increased, platelet count decreased, prothrombin time prolonged, rectal haemorrhage, upper gastrointestinal haemorrhage, . ALBUMINAR dosage: unknown. Patient was hospitalized. Patient recovered.

Revlimid Side Effects Report #5494035-8
Consumer or non-health professional from UNITED STATES reported REVLIMID problem on Oct 17, 2007. Female patient, 94 years of age, weighting 189.4 lb, was diagnosed with acute myeloid leukaemia and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: anaemia, cardiac arrest, catheter site haemorrhage, pulmonary oedema, refusal of treatment by relative, respiratory distress, respiratory failure, thrombocytopenia, . REVLIMID dosage: 50 MG, QD FOR MAX 28 DAYS, ORAL. During the same period patient was treated with METOPROLOL TARTRATE, DIGOXIN, CALCIUM, MAGNESIUM SULPHATE, CENTRUM, LASIX. Patient was hospitalized. Patient died on 08/10/2007.

Eptifibatide Side Effects Report #5458021-6
EPTIFIBATIDE problem was reported by a Physician from CANADA on Sept 06, 2007. Male patient, 70 years of age, weighting 222.7 lb, was diagnosed with acute coronary syndrome and was treated with EPTIFIBATIDE. After drug was administered, patient experienced the following problems/side effects: arthralgia, catheter site haematoma, catheter site haemorrhage, gout, retroperitoneal haemorrhage, weight bearing difficulty, . EPTIFIBATIDE dosage: unknown. During the same period patient was treated with ASPIRIN, ATORVASTATIN CALCIUM, CLOPIDOGREL, METFORMIN, METOPROLOL, RABEPRAZOLE, RAMIPRIL, AVANDIA. Patient was hospitalized. Patient recovered.

Milrinone Side Effects Report #5415652-7
Consumer or non-health professional from UNITED STATES reported MILRINONE problem on Aug 07, 2007. Male patient, 18 years of age, was treated with MILRINONE. After drug was administered, patient experienced the following problems/side effects: azotaemia, blood pressure decreased, catheter site haemorrhage, device failure, hepatic necrosis, multi-organ failure, pneumothorax, renal failure, septic shock, . MILRINONE dosage: unknown. During the same period patient was treated with HEPARIN, TAZICEF, GENTAMICIN, SULCONAZOLE, PEPCID, VASOPRESSIN, EPINEPHRINE, NOREPINEPHRINE. Patient died on 07/23/2007.

Byetta Side Effects Report #5772441-1
BYETTA problem was reported by a Physician from UNITED STATES on June 03, 2008. Female patient, weighting 198.0 lb, was diagnosed with type 2 diabetes mellitus, blood glucose abnormal, osteoporosis, gastrooesophageal reflux disease and was treated with BYETTA. After drug was administered, patient experienced the following problems/side effects: bronchitis, catheter site haematoma, catheter site haemorrhage, cough, decreased appetite, hypersensitivity, peripheral vascular disorder, . BYETTA dosage: unknown. During the same period patient was treated with LANTUS, HUMALOG, AMARYL, METFORMIN, PROTONIX, FOLIC ACID. Patient recovered.

Augmentin Side Effects Report #5731855-6
Consumer or non-health professional from SWITZERLAND reported AUGMENTIN problem on May 06, 2008. Female patient, 86 years of age, was diagnosed with lung infection, catheterisation cardiac, cardiogenic shock and was treated with AUGMENTIN. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, cardiogenic shock, catheter site haemorrhage, lung infection, thrombocytopenia, ventricular tachycardia, . AUGMENTIN dosage: 1200MG THREE TIMES PER DAY. During the same period patient was treated with REOPRO, LIQUAEMIN, CORDARONE, LIDOCAINE, PRIMPERAN, VISIPAQUE, DOBUTAMINE HYDROCHLORIDE, LASIX. Patient was hospitalized. Patient recovered.

Augmentin Side Effects Report #5736430-5
AUGMENTIN problem was reported by a Consumer or non-health professional from SWITZERLAND on May 09, 2008. Female patient, 86 years of age, was diagnosed with lung infection, cardiogenic shock and was treated with AUGMENTIN. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, cardiogenic shock, catheter site haemorrhage, lung infection, thrombocytopenia, ventricular tachycardia, . AUGMENTIN dosage: 1200MG THREE TIMES PER DAY. During the same period patient was treated with REOPRO, LIQUAEMIN, CORDARONE, LIDOCAINE, PRIMPERAN, VISIPAQUE, DOBUTAMINE HYDROCHLORIDE, LASIX. Patient was hospitalized. Patient recovered.

Augmentin Side Effects Report #5736435-4
Consumer or non-health professional from SWITZERLAND reported AUGMENTIN problem on May 09, 2008. Female patient, 86 years of age, was diagnosed with lung infection, cardiogenic shock and was treated with AUGMENTIN. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, cardiogenic shock, catheter site haemorrhage, lung infection, thrombocytopenia, ventricular tachycardia, . AUGMENTIN dosage: 1200MG THREE TIMES PER DAY. During the same period patient was treated with REOPRO, LIQUAEMIN, CORDARONE, LIDOCAINE, PRIMPERAN, VISIPAQUE, DOBUTAMINE HYDROCHLORIDE, LASIX. Patient was hospitalized. Patient recovered.

Reopro Side Effects Report #5712222-8
REOPRO problem was reported by a Physician from SWITZERLAND on Apr 10, 2008. Female patient, 86 years of age, was diagnosed with catheterisation cardiac, lung infection, cardiogenic shock and was treated with REOPRO. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, cardiogenic shock, catheter site haemorrhage, lung infection, thrombocytopenia, ventricular tachycardia, . REOPRO dosage: unknown. During the same period patient was treated with AUGMENTIN, LIQUAEMIN, CORDARONE, LIDOCAINE, PRIMPERAN, VISIPAQUE, DOBUTAMINE HYDROCHLORIDE. Patient was hospitalized. Patient recovered.

Tracleer Side Effects Report #5348373-X
Physician from JAPAN reported TRACLEER problem on May 20, 2007. Female patient, 36 years of age, weighting 90.39 lb, was diagnosed with pulmonary hypertension and was treated with TRACLEER. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, anaemia, catheter site haemorrhage, haematoma, haemoglobin decreased, headache, hepatic function abnormal, nausea, . TRACLEER dosage: unknown. During the same period patient was treated with FLOLAN, VIAGRA, SPIRONOLACTONE, PIMOBENDAN, RANITIDINE, TORSEMIDE, MOSAPRIDE. Patient was hospitalized. Patient recovered.

Duragesic Side Effects Report #5360021-1
DURAGESIC problem was reported by a Consumer or non-health professional from UNITED STATES on June 07, 2007. Male patient, weighting 200.0 lb, was diagnosed with pain, neuralgia, anxiety and was treated with DURAGESIC. After drug was administered, patient experienced the following problems/side effects: application site infection, back pain, catheter site haemorrhage, catheter site infection, diplegia, inadequate analgesia, neuralgia, open wound, stomach discomfort, . DURAGESIC dosage: unknown. During the same period patient was treated with FENTANYL TRANSDERMAL SYSTEM, NEURONTIN, VALIUM, XANAX, OXYCODONE. Patient was hospitalized. Patient recovered.

Campath Side Effects Report #5321701-7
Health Professional from UNITED STATES reported CAMPATH problem on May 04, 2007. Male patient, 58 years of age, weighting 268.1 lb, was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: bacteraemia, catheter related infection, catheter site haemorrhage, cerebral atrophy, cholelithiasis, coagulopathy, dialysis, disseminated intravascular coagulation, enterococcal infection, . CAMPATH dosage: 30 MG, D1-5 EVERY 28 DAYS. During the same period patient was treated with FLUDARA. Patient was hospitalized. Patient died on 11/28/2006.

Flolan Side Effects Report #5284518-8
FLOLAN problem was reported by a Health Professional from UNITED STATES on Mar 29, 2007. Male patient, 23 years of age, weighting 123.0 lb, was treated with FLOLAN. After drug was administered, patient experienced the following problems/side effects: blood pressure increased, catheter related complication, catheter site haemorrhage, . FLOLAN dosage: unknown. During the same period patient was treated with INFUSION FLUID. Patient was hospitalized. Patient recovered.

PatientsVille.com does not provide medical advice, diagnosis or treatment. The information contained on PatientsVille.com site has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of adverse drug reactions or for establishing or changing of patient treatments.


Thank you for visiting Patientsville.com. We hope you found our information about CATHETER SITE HAEMORRHAGE side effects helpful. The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Thank you for visiting Patientsville.net. Hope you enjoyed finding information on medications and found answers to Your Questions about CATHETER SITE HAEMORRHAGE